This sub-division made comparison easier, but it must be remembered that different occupations would influence the first two stages.
The two groups, treated and controls, are compared in the table. This method of comparison, unfortunately, does not fulfil the requirements of a statistical approach and would probably not be considered valid by a purist. However, I plead my case on several points. Firstly, the long period of observation; and secondly, the similarity of the treated and control groups clillically. Little more can be expected from a clinical evaluation. The figures suggest that treatment with arsenicals has little effect on the coturse of the disease. This confirms the present-day opinion of most neurologists.
DIscusSION.
There is no known treatment of disseminated sclerosis which is generally accepted to influence favourably the course of the disease. Fashions in treatment come and go, and arsenicals have enjoyed a long regime and are still in favour in some clinics. In such a long-standing condition, it is only possible to evaluate treatment after many years. The literature contains only accounts of short-term therapy, general impressions, statements of faith and accounts of the treatment of one or two cases. The basis for the use of arsenicals in disseminated sclerosis was founded on the erroneous idea that it was spirochaetal ir aetiology (Siemerling, 1918) . Many authors have supported the use of intravenous arsenicals (Adams et al., 1924; Kalberlah, 1919; O; snato, 1928; Perrin, 1920; Prados and Such, 1922; Sauer, 1926; Schafsen, 1924; Stern-Piper, 1920) . Others have either found inconclusive results or decided against the use of arsenicals. (Fleck, 1921; Simmonds, 1920; Speer, 1920; Veraguth, 1924; Wichura, 1920) .
However, no attempt, as far as the author is aware, has been made to analyse the end-results after a number of years or compare them again.st a control series.
It was for this reason considered that present investigations were worth while despite the fact that arsenical treatment is not accepted at present in this department.
CONCLUSIONS. An attempt has been made to compare the course of the disease in ten patients suffering from disseminated sclerosis treated with intravenous arsenicals, with that of ten similar controls. No significant difference in clinical status could be seen about ten years later.
If the results of this investigation are generally true, it does not seem justifiable to submit patients to the real risk of toxic complications and the possibility of syringe jaundice.
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